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Abstract 
Background. Equine herpesvirus type 1 (EHV-1) is responsible for respiratory disease 
in young animals, abortion in pregnant mares and neurological disease, whilst equine 
herpesvirus 4 (EHV-4) is mainly the causative agent of  respiratory disorders and 
rarely causes abortion. These viruses are considered as one of  the most clinically and 
economically important pathogens of  horses and can be detected in a range of  tissues.
Scope and Approach. Serological methods are used to detect the presence and titre of  
specific antibodies to EHV-1 and EHV-4 in the sera of  examined horses and are useful 
in epizootiological studies. Commercially available ELISA kits are able to differentiate 
specific EHV-1 and EHV-4 antibodies. EHV-1 and EHV-4 can both be isolated using 
susceptible cells such as primary horse cell cultures and other non-equine cells with 
visible cytopathic effect. Since standard diagnostic methods can be time consuming and 
arduous, the scope of  many studies has been to develop and confirm the sensitivity and 
specificity of  molecular diagnostic methods. 
Key Findings and Conclusions. Polymerase chain reaction (PCR) has proved to be a good 
screening method for the presence of  latent infections of  horses caused by these 
viruses, also making possible the rapid identification and differentiation of  EHV-1 and-
EHV-4 in the examined samples. Real-time PCR is a sensitive, specific and quantitative 
method that enables the determination of  viral kinetics in infected horses. Genome 
sequencing can be used to discover mutations in the genomes of  EHV-1 and EHV-4 as 
well as to track the spread of  their different strains globally. 
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INTRODUCTION
At first, before 1981, equine herpesvirus type 1 (EHV-1) and equine herpesvirus 
type 4 (EHV-4) were considered as two subtypes of  the same virus commonly 
named “equine rhinopneumonitis virus” and “equine abortion virus” (Crabb and 
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Studdert 1996). Information based on genome sequencing confirmed that EHV-1 
and EHV-4 are actually two closely related, but different viruses, with an amino acid 
sequence identity ranging between 54.9% and 96.4% (Telford et al., 1998). To date, 
EHV-1 and EHV-4 are both classified as members of  the genus Varicellovirus in the 
Alphaherpesviridae family (Patel and Heldens, 2005; Davison et al., 2009). Antigenic 
cross reactivity of  these two viruses is a consequence of  their genetic relatedness and 
it often hinders the use of  serological methods for differentiation purposes (Allen 
and Bryans, 1986; Carvalho et al., 2000; Kydd et al., 2006). EHV-1 is responsible for 
respiratory disease in young animals, abortion in pregnant mares and neurological 
disease, whilst EHV-4 is mainly the causative agent of  respiratory disorders and 
rarely causes abortion. The first isolation and identification of  EHV-1 in Serbia was 
performed by Mihajlović et al. (1987). Both EHV-1 and EHV-4 are endemic in horse 
populations worldwide (Campbell and Studdert 1983; Allen and Bryans 1986; Reed 
and Toribio, 2004; Marenzoni et al., 2008). These viruses may cause latent infection 
in lymphoid tissue and the sensory and trigeminal ganglions. The influence of  stress, 
transport, co-mingling of  horses as well as intercurrent disease can lead to virus 
reactivation in asymptomatic carrier horses and consequently to the spread of  the 
disease in the equine population (Campbell and Studdert 1983; Welch et al., 1992; 
Slater et al., 1994; Kydd et al. 1994; Allen, 2006; Pusterla et al., 2010). EHV-1 and 
EHV-4 are considered as one of  the most clinically and economically important 
pathogens of  horses. Extensive outbreaks of  abortion, perinatal/neonatal foal death 
as well as neurological and respiratory disorders are a significant cause of  economic 
loss to the equine industry and thus effective diagnosis, control and prevention of  
equine herpes viral disease remains necessary (Allen and Bryans, 1986; Yasunaga et al., 
1998; Gilkerson et al., 1999; Studdert et al., 2003). These viruses can be detected in a 
range of  tissues including lung, kidney, liver, spleen, trigeminal ganglia, submandibular 
lymph nodes including nasal swabs, placenta and blood of  live horses (Borchers et 
al., 1997; Dunowska et al., 2002; Hornyák et al., 2006; Diallo et al., 2007; Ataseven 
et al., 2009; Pusterla et al., 2010; Pusterla et al., 2012; Turan et al., 2012). A variety of  
methods can be utilized for detection and differentiation of  EHV-1 and EHV-4 in 
clinical samples, including virus isolation, serology, polymerase chain reaction (PCR), 
real-time PCR and sequencing (Yasunaga et al., 1998; Diallo et al., 2007; Ataseven et 
al., 2009; Turan et al., 2012; OIE, 2015).
Serological testing has proved to be a reliable tool for presumptive evidence of  
infection and/or vaccination status in animals (Milić et al., 1997; Milić et al., 1998; Milić 
et al., 1999; Yasunaga et al., 2000; Milić et al., 2001; Kydd et al. 2006; Milić et al. 2009; 
Nišavić et al., 2016). Furthermore, the use of  serology is necessary in epizootiological 
studies that form a base for eradication programs of  numerous infectious diseases 
of  animals (Lazić et al., 1993; Yasunaga et al., 1998; Ataseven et al., 2009; Petrović et 
al., 2015; Lazić et al., 2016). Increase in antibody titre (4-fold or higher) detected by 
virus-neutralization test (VNT) or complement fixation test (CFT) in blood serum 
samples collected 7–21 days apart, provide evidence of  recent EHV infection (Kydd 
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et al. 2006). In the study performed by Senthil and Parameswaran (2014) a total of  
162 horse sera samples were subjected to VNT using Madin–Darby bovine kidney 
cell line (MDBK) adapted EHV-1 antigen and 53 (32.7 %) were found to be positive 
for EHV-1 specific antibodies. This test was used to detect the seroprevalence as well 
as the highest antibody titre in seropositive animals. Dunowska et al. (2002) reported 
that out of  the 82 sera tested by VNT, 59 (70 %) showed neutralization antibodies to 
EHV-1 among horses in New Zealand. However, a disadvantage of  VNT and CFT 
is the inability of  discrimination between antibodies to EHV-1 and EHV-4 (Carvalho 
et al., 2000; Hartley et al., 2005; Kydd et al.2006; OIE, 2015). A type-specific ELISA 
using fusion proteins expressing variable regions of  glycoprotein G (gG) has been 
developed by Crabb and Studdert (1993), providing for the first time the opportunity 
to differentiate antibodies to these viruses; the type specificity of  this test has been 
confirmed in many studies (Crabb et al., 1995; Glikerson et al., 1997; Yasunaga et al, 
1998; Yasunaga et al., 2000). Commercially available ELISA kits e.g. Svanovir EHV-
1/EHV-4-Ab ELISA are able to differentiate specific EHV-1 and EHV-4 antibodies 
(Studdert et al., 2003; Hartley et al., 2005; Gür and Yapici 2008; Ataseven et al., 2009).
EHV-1 and EHV-4 can both be isolated using primary equine fetal kidney cells or cell 
strains of  equine fibroblasts derived from dermal (E-Derm) or lung tissue. It can be 
convenient to inoculate samples into both non-equine and equine cells in parallel to 
distinguish between EHV-1 and EHV-4, since equine-derived cell cultures should be 
used for successful isolation of  EHV-4 (OIE, 2015). The study of  Ploszay et al. (2013) 
describes the first successful isolation of  EHV-4 from Polish horses on Vero cells; 
however, there was no correlation between the results of  PCR and virus isolation since 
some samples that were PCR-positive yielded negative results in the isolation test. The 
authors concluded that the right choice of  susceptible cells such as primary horse 
cell cultures as well as proper sample collection, transportation and handling, might 
be important when isolating EHV-4. EHV-1 can be isolated on other cell types e.g. 
rabbit kidney (RK-13), baby hamster kidney (BHK-21), Madin–Darby bovine kidney 
(MDBK), pig kidney (PK-15) and Vero cells. Virus identity may be confirmed by PCR 
or by immunofluorescence with specific antisera (Dunowska et al., 2002; OIE, 2015).
Despite being considered “gold standard”, standard virological methods are often 
very arduous and time consuming, particularly when examining numerous samples, 
which led to the requirement for the implementation of  molecular methods in 
standard laboratory procedures in the diagnostics of  many animal viruses (Carvalho 
et al., 2000; Milić et al., 2010; Nišavić et al., 2010; Ohta et al., 2011; Nišavić et al., 
2016). Furthermore, given its sensitivity, PCR is a suitable screening method for 
latent EHV-1 and EHV-4 infection in horses (Welch et al., 1992; Kirisawa et al., 
1993; Borchers et al., 1997; Allen, 2006, Pusterla et al., 2012). Hornyák et al. (2006) 
compared the sensitivity of  PCR and virus isolation for the detection of  EHV-1 in 
organ samples of  aborted foals. Despite the fact that the results of  virus isolation 
and PCR correlated with each other, PCR proved to be more sensitive detecting the 
virus in 27 samples in contrast to virus isolation which was successful for 25 samples. 
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Ohta et al. (2011) evaluated the usefulness of  PCR for diagnosis of  respiratory disease 
induced by EHV-1. The authors used PCR primers for glycoprotein C (gC) previously 
described by Lawrence et al. (1994) and concluded that it can be introduced to routine 
practice in order to make an early diagnosis of  EHV-1 infection. Pusterla et al. (2012) 
examined the prevalence of  latent alphaherpesviruses in submandibular (SMLN) and 
bronchial lymph (BLN) nodes, as well as from the trigeminal ganglia (TG) of  70 racing 
thoroughbred horses. In this study, eighteen (25.7  %) and 58 (82.8%) horses were 
PCR positive for the gB gene of  EHV-1 and EHV-4, respectively, in at least one of  the 
three tissues sampled. The distribution of  latent EHV-1 and EHV-4 infection varied 
in the examined samples, whilst the TG were found to be most commonly infected. 
Borchers et al. (1997) applied nested-PCR and in situ PCR to study the tropism of  
EHV-4 and their results proved that EHV-4 establishes latency in the TG. Kirisawa et 
al. (1993) developed a PCR system that could differentiate EHV-1 and EHV-4 types 
rapidly and applied this technique on specimens from aborted fetuses. The authors 
designed primers for PCR from aligned nucleotide sequences of  glycoprotein B genes 
of  EHV-1 and EHV-4 to amplify specific regions for EHV-1 or EHV-4. By using 
type specific primer mixture, amplified fragments were identified as EHV-1 or EHV-
4 in a one-step reaction in spite of  the high degree of  sequence homology. Another 
advantage of  this technique was the possibility of  rapid detection of  mixed infections 
in horses and it has been applied by numerous authors (Wang et al., 2007; Hebia-
Fellah et al., 2009; Ploszay et al., 2013). The objective of  the study of  Hebia-Fellah et 
al. (2009) was to assess the possible risks for the horizontal transmission of  EHV-1 
and EHV-4 via semen in an equine population. Examination of  the semen involved 
the detection of  viral DNA using specific PCR as previously described by Kirisawa 
et al. (1993). EHV-4 viral DNA was not detected in any of  the semen samples, 
whilst EHV-1 DNA was identified in 51 of  the 390 samples (13 %). The results 
obtained indicate that EHV-1 may be transmitted via semen at mating or by artificial 
insemination. Wang et al. (2007) developed a nested multiplex PCR as a rapid (<12 
h), sensitive test for the simultaneous identification of  equine herpesviruses (EHV-1, 
EHV-4, EHV-2 and EHV-5) in clinical samples from horses without clinical signs of  
respiratory disease. Multiplex PCR was verified as a sensitive and specific technique 
for the detection of  EHV in clinical samples as well as cell culture. The detection of  
up to three EHVs in the same sample was enabled by a combination of  multiplex 
PCR and cell culture or direct multiplex PCR. Similarly, Ataseven et al. (2009) pointed 
out that virus isolation in conjunction with nested multiplex PCR assay would lead to 
a higher virus identification rate in multiple respiratory infections caused by EHV-1 
and EHV-4. Virus isolation and detection was performed on nasal swab samples and 
buffy coat cells from horses showing signs of  respiratory disease. Two samples that 
tested positive for EHV-1 and EHV-4 specific DNA by multiplex nested PCR gave no 
EHV-specific cytopathic effects in cell culture. In the study of  Carvalho et al. (2000) a 
multiplex PCR procedure was developed for differentiation of  strains and field isolates 
of  EHV-1 and EHV-4. Specific oligonucleotide primers were designed to amplify the 
thymidine kinase (TK) gene region of  EHV-1 and EHV-4 and the obtained results 
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confirmed that the genome structures of  EHV-1 and EHV-4 within the chosen TK 
gene region are highly conserved. This PCR assay proved to be sensitive and specific 
for the diagnosis of  field isolates of  EHV-1 and -4 and it was proposed for use as a 
rapid method for screening large numbers of  horses in epidemiological surveys.
In addition to successful identification of  various animal viruses in clinical samples, 
the application of  molecular methods enables the molecular characterization of  the 
viruses, i.e., genotyping which is significant regarding surveillance purposes (Milić et 
al., 2012; Turan et al., 2012; Milić et al., 2015; Ataseven et al., 2016). Real-time PCR 
technology is a rapid, sensitive, specific and quantitative method for the diagnosis 
of  infectious diseases that grants the possibility of  differentiating between diverse 
viral states (Hussey et al., 2006; Diallo et al., 2007; Slater, 2007; Pusterla et al., 2009; 
Milić et al., 2010). The OIE Reference Laboratories use quantitative real-time PCR 
assays that target heterologous sequences of  major glycoprotein genes to distinguish 
between EHV-1 and EHV-4 (OIE, 2015). A multiplex real time PCR targeting gB 
gene of  EHV-1 and EHV-4 was presented by Diallo et al. (2007). The authors have 
demonstrated that a multiplex real-time PCR can be successfully used to detect and 
differentiate the closely related EHV-1 and EHV-4. The test can be used as a one-tube 
reaction and proved to be rapid, sensitive and specific. Ko et al. (2013) examined the 
prevalence of  equine respiratory virus infections among a suspected population of  
race horses in Republic of  Korea. The nasal swabs of  1,574 horses were examined 
by real-time PCR using primers described by Diallo et al. (2007). The results of  this 
investigation implied that equine respiratory viruses are endemic at Seoul Race Park 
whilst the molecular prevalence rates of  EHV-1 and EHV-4 were 5.6 % and 7.9 %, 
respectively. Hussey et al. (2006) developed and validated a real-time PCR diagnostic 
assay for detection of  EHV-1 in equine nasal and blood samples and compared its 
performance with virus isolation on cell culture. The target sequence for real-time PCR 
was a region of  the EHV-1 gB gene that is sufficiently different from the EHV-4 gB 
gene. The authors concluded that the potential for rapid diagnosis, high throughput, 
as well as sensitivity and quantitative nature of  the real-time PCR test all make it 
highly suitable to replace virus isolation for both surveillance and diagnostic and 
research purposes. The results published by Pusterla et al. (2009) showed that the viral 
load, strain and state of  EHV-1 in the blood and nasopharyngeal secretions of  adult 
horses can sucessfully be determined using real-time PCR. The authors proposed this 
molecular approach to help assess the risk of  exposure to other horses and permit 
determination of  viral kinetics in infected horses. Turan et al. (2012) conducted 
molecular and pathological investigations of  EHV-1 and EHV-4 infections in horses 
in Turkey in order to investigate abortion storms that occurred in the Marmara region 
using real-time PCR. The method used for the real-time PCR was similar to those 
reported by Diallo et al. (2007). Nucleotide sequencing of  positive PCR products was 
performed in order to establish the phylogenetic relationship between the EHV strains. 
The alignment indicated that the Turkish EHV-1 isolates were homogenous, although 
one was grouped with other EHV-1 strains from the United Kingdom, Germany and 
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from the United States. Turkish EHV-1 isolates were grouped in a clade of  their own, 
but were closely related to a European strain of  EHV-1. The EHV-4 strain clustered 
with EHV-4 strains from the United Kingdom and Australia based on their sequence 
similarities. Ataseven et al. (2016) performed the partial characterization of  Turkish 
(TR) EHV-1 field strains based on gB gene using a novel designed primer set for EHV-
1. The results of  the molecular investigation of  Turkish EHV-1 strains contributed 
to the monitoring of  EHV-1 infection in Turkey and showed that these strains were 
closely related to the European EHV-1 strains.
CONCLUSION
EHV-1 and EHV-4 are one of  the most important viral pathogens of  horses that 
cause major economic loss to the equine industry around the world. Therefore, control 
and prevention of  equine herpes viral disease based on proper and timely diagnosis 
remains vital. Serological methods are used to detect the presence and titre of  specific 
antibodies to EHV-1 and EHV-4 in the sera of  examined horses, enabling an overview 
of  the population in epizootiological studies. The inability of  discrimination between 
antibodies to EHV-1 or EHV-4 by VNT and CFT are overcome by the use of  type-
specific ELISA using fusion proteins expressing variable regions of  the glycoprotein 
G protein of  these two viruses. EHV-1 and EHV-4 can both be isolated using 
susceptible cells such as primary horse cell cultures as well as some other non-equine 
cells with visible cytopathic effect (CPE) and may further be confirmed by PCR or 
by immunofluorescence with specific antisera. Since these standard methods are 
time consuming and laborious, especially when examining numerous samples, many 
authors have developed and confirmed the sensitivity and specificity of  molecular 
diagnostic methods (PCR, real-time PCR, sequencing). Apart from making possible 
the rapid identification and differentiation of  EHV-1 and-EHV-4 in the examined 
samples, PCR has proved to be a good screening method for the presence of  latent 
infections of  horses caused by these viruses. Real-time PCR is a sensitive, specific and 
quantitative method that permits the determination of  viral kinetics in infected horses, 
whilst the application of  genome sequencing is significant for molecular epidemiology 
since it enables the detection of  mutations in the genomes of  EHV-1 and EHV-4, as 
well as the tracking of  the spread of  these different strains globally. 
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STANDARDNE I MOLEKULARNE METODE DIJAGNOSTIKE 
INFEKCIJA IZAZVANIH KONJSKIM HERPESVIRUSIMA 1 I 4 
MILIĆ Nenad, RADALJ Andrea, NIŠAVIĆ Jakov
Kratak sadržaj
Uvod. Konjski herpesvirus 1 (EHV-1) izaziva respiratorne infekcije mladih konja, 
promene u CNS-u i pojavu abortusa kod gravidnih kobila. Infekcije izazvane konjskim 
herpesvirusom 4 (EHV-4) se manifestuju ispoljavanjem respiratornih simptoma 
oboljenja kod životinja, a ređe pojavom abortusa. Infekcije izazvane prethodno 
navedenim virusima prisutne su u populaciji konja širom sveta. 
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Cilj i pristup. U cilju laboratorijske dijagnostike, odnosno izrade odgovarajućih 
epizootioloških studija o prisustvu virusa EHV-1 i EHV-4 u populaciji konja na 
određenom prostoru, primenjuju se serološke metode kao što su ELISA ili test virus 
neutralizacije. Primenom navedenih metoda se vrši otkrivanje prisustva i titra specifičnih 
antitela protiv prethodno navedenih virusa u uzorcima krvnih seruma konja. Ovde 
treba napomenuti da su danas dostupni i komercijalni kitovi za izvođenje metode 
ELISA koji omogućavaju diferencijaciju specifičnih EHV-1 i EHV-4 antitela. Konjski 
herpesvirus 1 i konjski herpesvirus 4 se mogu izolovati na kulturama ćelija poreklom 
od konja, kao i na drugim ćelijskim linijama, a daju karakterističan citopatogeni efekat. 
Pored navedenih klasičnih virusoloških metoda, danas su u upotrebi i molekularne 
metode dijagnostike kao što su PCR ili real-time PCR. 
Ključni nalazi i zaključak. Lančana reakcija polimeraze (PCR) predstavlja pogodnu 
screening metodu za brzo i pouzdano otkrivanje prisustva virusa EHV-1 i EHV-4 u 
ispitivanim uzorcima poreklom od konja. Real-time PCR je osetljiva, specifična i 
kvantitativna metoda čijom primenom se takođe može utvrditi prisustvo navedenih 
virusa u organizmu konja. Metodom sekvenciranja genoma virusa EHV-1 i EHV-4 
se mogu utvrditi sličnosti ili razlike između pojedinih sojeva virusa, odnosno može 
se izvršiti molekularna karakterizacija sojeva virusa EHV-1 i EHV-4 dominantno 
prisutnih u populaciji konja na određenoj teritoriji. 
Ključne reči: EHV-1, EHV-4, PCR, serologija, sekvenciranje, izolacija virusa
